Lymphoid leukemia
Conditions
Interventions
Experimental group: 10 children undergoing leukemia treatment.
Control Group: 10 healthy children.
Both groups will undergo cardiac variability assessment 10 minutes before and 10 minutes after the
Other
E02.779
Sponsors
Universidade Estadual Paulista
Universidade Estadual Paulista
Eligibility
Age
4 Years to 15 Years
Inclusion criteria
Inclusion criteria: Children and adolescents on leukemia treatment; both genders; age range 4 - 15 years old.
Exclusion criteria
Exclusion criteria: Volunteers with lung, neurological, or drug-related illnesses in addition to those used to treat leukemia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1 We expect to find an acute reduction of the Heart Rate Variability by Autonomic Overload, represented by the rMSSD and HF index;Found Outcome 1 There was no significant reduction in cardiac variability by autonomic overload, represented by the rMSSD and HF index. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Public ContactVitor Valenti
Universidade Estadual Paulista
Outcome results
None listed